IIA
LSTA icon

IPG Investment Advisors’s Lisata Therapeutics LSTA Stock Holding History

IPG Investment Advisors’s Portfolio LSTA Stock Details LSTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-9,170
Closed -$73K – 167
2022
Q2 		$73K Buy
+9,170
New +$75.5K 0.02% 141

Other funds holding LSTA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CW
Cook Wealth Raleigh, North Carolina $206M AUM 4.73% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

IPG Investment Advisors's LSTA Position: Q3 2022 in Review

IPG Investment Advisors sold out of Lisata Therapeutics (LSTA) in Q3 2022, closing a stake of 9,170 shares — an estimated $73K sold.

IPG Investment Advisors first reported a position in LSTA in Q2 2022 and held it in 1 quarter. The position peaked at $73K in Q2 2022. 22 funds tracked by Wall St. Rank hold LSTA as of Q3 2022.

  • IPG Investment Advisors reported no remaining Lisata Therapeutics position as of Q3 2022 after selling out during the quarter.
  • IPG Investment Advisors sold 9,170 Lisata Therapeutics shares in Q3 2022, an estimated $73K.
  • IPG Investment Advisors first reported a position in Lisata Therapeutics in Q2 2022 and held it in 1 quarter.
  • IPG Investment Advisors's Lisata Therapeutics position peaked at $73K in Q2 2022.
  • 22 funds tracked by Wall St. Rank held Lisata Therapeutics as of Q3 2022.

Based on IPG Investment Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.